- The Foundry: Conservative Policy News Blog from The Heritage Foundation - http://blog.heritage.org -
An Opportunity to Improve the FDA
Posted By Kathryn Nix On February 3, 2012 @ 11:15 am In Obamacare | Comments Disabled
This year, Congress will have to reauthorize the Prescription Drug User Fee Act (PDUFA), which funds the Food and Drug Administration’s (FDA) drug approval process. As noted  by Amanda Kronquist, a Heritage Health Policy Graduate Fellow, the FDA drug approval process has become “increasingly unpredictable, uncertain, and inefficient.”
The House Energy and Commerce Subcommittee on Health held its first hearing  this year on the topic yesterday. It heard from the FDA commissioner and others in the field on the PDUFA reauthorization and its effect on jobs, innovation, and patients.
Congress should use the reauthorization of PDUFA to improve the drug approval process and avoid adding more complicating regulations, since maintaining and improving the United States’ global competitive edge in the production of prescription drugs and medical devices is critical to the quality of our health care system and the economy.
Article printed from The Foundry: Conservative Policy News Blog from The Heritage Foundation: http://blog.heritage.org
URL to article: http://blog.heritage.org/2012/02/03/an-opportunity-to-improve-the-fda/
URLs in this post:
 Image: http://blog.heritage.org/wp-content/uploads/prescription-drugs.jpg
 noted: http://www.heritage.org/research/reports/2011/12/the-prescription-drug-user-fee-act-history-and-reauthorization-issues-for-2012
 hearing: http://energycommerce.house.gov/hearings/hearingdetail.aspx?NewsID=9194
Copyright © 2011 The Heritage Foundation. All rights reserved.